US Pharma & Biotech Oncology - PPC Market Share Analysis February 2025

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Oncology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Market Exposure

Share of Clicks for top 10 US Pharma & biotech Oncology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month
Domain	Share of clicks
keytruda.com	5.51
cancer.org	4.72
breyanzi.com	4.01
mayoclinic.org	3.45
kisqali.com	2.5
her2empowered.com	2.4
kisqali-hcp.com	2.13
abecma.com	2.13
lilly.com	2.1
darzalex.com	2.09
others	68.96

In the oncology PPC landscape, “others” dominate with 68.96% click share. Keytruda.com leads individual domains at 5.51%, followed by cancer.org at 4.72% and breyanzi.com at 4.01%.

Market Exposure

Share of Spend for the top 10 US Pharma & biotech Oncology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month
Date	keytruda.com	cancer.org	kisqali.com	her2empowered.com	trodelvy.com	breyanzi.com	nubeqa-us.com	kisqali-hcp.com	abecma.com	lilly.com
2025/01/01	9.01%	2.21%	0.22%	2.44%	0.41%	2.37%	2.85%	0.07%	1.44%	7.75%
2025/01/02	7.41%	1.14%	12.91%	2.3%	2.31%	2.12%	3.66%	7.54%	1.57%	6.39%
2025/01/03	7.65%	2.15%	5.69%	2.43%	2.22%	1.33%	3.39%	3.19%	1.84%	6.4%
2025/01/04	7.89%	1.87%	4.89%	2.65%	2.69%	2.3%	3.67%	3.91%	2.77%	5.13%
2025/01/05	5.15%	2.72%	4.87%	3.79%	3.06%	2.06%	4.22%	4.76%	2.16%	4.69%
2025/01/06	6.24%	1.23%	6.8%	2.05%	1.73%	1.83%	2.85%	5.62%	1.32%	5.16%
2025/01/07	6.42%	0.39%	7.39%	1.97%	2.34%	2.18%	2.45%	5.86%	1.14%	4.89%
2025/01/08	7.21%	2.29%	7.47%	2.11%	1.97%	1.78%	2.45%	6.01%	1.3%	6.18%
2025/01/09	6.18%	2.09%	7.57%	2.59%	2.22%	2.08%	2.96%	6.09%	1.66%	4.7%
2025/01/10	6.44%	1.42%	6.37%	2.56%	1.97%	2.6%	2.71%	4.88%	1.05%	3.05%
2025/01/11	7.49%	2.23%	3.37%	2.75%	2.2%	2.86%	2.18%	3.18%	1.27%	6.53%
2025/01/12	5.24%	1.52%	5.49%	2.6%	1.82%	3.22%	2.87%	5.13%	1.08%	4.72%
2025/01/13	6.35%	1.29%	9.62%	2.34%	2.7%	3.7%	3.88%	5.43%	1.56%	4.76%
2025/01/14	6.35%	2.39%	5.77%	3.36%	2.72%	3.23%	2.49%	4.35%	1.44%	4.93%
2025/01/15	7.09%	2.25%	7.36%	2.08%	1.94%	1.75%	2.41%	5.92%	1.28%	5.99%
2025/01/16	6.09%	2.07%	7.49%	2.56%	2.19%	2.05%	2.92%	6.02%	1.63%	4.45%
2025/01/21	0.44%	2.2%	0.43%	5.11%	5.32%	6.68%	5.86%	0.72%	4.77%	0.4%
2025/01/22	0.34%	2.93%	0.72%	5.64%	4%	7.16%	4.48%	0.68%	4.31%	0.47%
2025/01/23	3.92%	1.96%	4.7%	4.46%	2.07%	4.29%	3.3%	4.2%	2.33%	1.08%
2025/01/24	1.96%	2.75%	3.53%	3.87%	2.5%	4.08%	3.24%	2.79%	2.27%	2.39%
2025/01/25	0.59%	3.8%	1.22%	4.33%	2.9%	5.13%	2.45%	1.12%	4.28%	0.35%
2025/01/26	1.98%	3.34%	4.03%	4.29%	2.92%	5.47%	3.27%	2.33%	5.76%	2.04%
2025/01/27	2.51%	3.24%	3.01%	3.85%	3.26%	5.29%	3.42%	1.8%	4.98%	0.8%
2025/01/28	4.14%	2.92%	4.45%	3.8%	3.61%	6.02%	3.87%	3.06%	3.19%	2.56%
2025/01/29	6.16%	1.75%	5.85%	3.72%	2.81%	3.93%	2.82%	3.96%	1.83%	3.08%
2025/01/30	5.77%	2.21%	5.23%	4.09%	3.28%	4.53%	2.8%	3.93%	1.96%	2.18%
2025/01/31	5.92%	4.25%	3.72%	3.28%	3.19%	3.08%	2.87%	2.62%	2%	1.51%

January saw dynamic shifts in PPC spend share. Keytruda.com started strong but dipped mid-month, recovering slightly by month’s end. Cancer.org maintained a steady climb, peaking on January 31. Kisqali.com experienced fluctuations, with a notable spike early in the month. Her2empowered.com and Trodelvy.com showed consistent growth, while Breyanzi.com surged in the latter half. Nubeqa-us.com and Kisqali-hcp.com had moderate increases. Abecma.com and Lilly.com faced declines, with Lilly.com dropping significantly mid-month.

Market Exposure

Competitor Count for US Pharma & biotech Oncology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month
Date	Competitor Count
2025/01/01	554
2025/01/02	515
2025/01/03	543
2025/01/04	523
2025/01/05	513
2025/01/06	544
2025/01/07	524
2025/01/08	532
2025/01/09	502
2025/01/10	523
2025/01/11	533
2025/01/12	534
2025/01/13	514
2025/01/14	512
2025/01/15	532
2025/01/16	502
2025/01/21	527
2025/01/22	539
2025/01/23	571
2025/01/24	555
2025/01/25	554
2025/01/26	532
2025/01/27	558
2025/01/28	541
2025/01/29	573
2025/01/30	602
2025/01/31	584

January saw fluctuating advertiser numbers, starting at 554 and dipping mid-month. A surge occurred late month, peaking at 602, ending at 584.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & biotech Oncology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month
Name	Market Trend
letschatcart.com	3.57%
breyanzi.com	2.31%
abecma.com	1.92%
mmissionpossible.co	1.48%
cardinalhealth.com	1.37%
kisqali-hcp.com	-1.55%
kisqali.com	-1.65%
lilly.com	-1.75%
mayoclinic.org	-2.12%
keytruda.com	-3.65%

In the past month, letschatcart.com surged with a 3.57% click share increase, while keytruda.com faced a 3.65% decline.

Campaign Efficiency

US Pharma & biotech Oncology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	letschatcart.com	breyanzi.com	cancer.org	her2empowered.com	abecma.com	keytruda.com	kisqali-hcp.com	lilly.com	kisqali.com	mayoclinic.org
2025/01/01	0.28%	2.62%	3.26%	2.84%	1.23%	3.54%	0.04%	3.33%	0.05%	1.63%
2025/01/02	0.22%	1.97%	1.82%	3.47%	1.9%	3.82%	6.05%	3.24%	4.89%	2.29%
2025/01/03	0.46%	1.68%	1.96%	2.99%	2.68%	2.77%	2.62%	2.36%	2.16%	1.34%
2025/01/04	0.93%	4.07%	2.93%	3.17%	3.59%	3.37%	2.67%	1.9%	2%	1.77%
2025/01/05	0.88%	3.27%	3.34%	4.41%	2%	1.66%	3.32%	1.84%	1.77%	2.75%
2025/01/06	0.41%	2.97%	1.45%	2.56%	1.33%	2.59%	4.07%	3.06%	2.73%	3.83%
2025/01/07	0.27%	3.8%	0.38%	2.46%	0.88%	2.48%	4.7%	2.7%	3.55%	3.86%
2025/01/08	0.54%	2.94%	2.53%	2.65%	1.24%	2.9%	4.43%	2.94%	3.1%	2.23%
2025/01/09	0.48%	3.66%	2.38%	3.17%	2.37%	2.49%	4.66%	2.75%	3.47%	3.89%
2025/01/10	0.31%	3.43%	1.59%	3.03%	0.75%	2.52%	4.02%	1.97%	3.55%	2.73%
2025/01/11	0.53%	4.09%	2.99%	3.12%	1.1%	3.13%	3.05%	2.66%	2.43%	3.11%
2025/01/12	0.44%	4.57%	2.18%	2.93%	0.74%	1.91%	4.2%	2.59%	3.41%	2.47%
2025/01/13	0.43%	6.44%	1.78%	3.23%	1.42%	2.63%	4.41%	2.97%	5.04%	2.11%
2025/01/14	0.81%	4.7%	2.66%	4.31%	1.31%	2.35%	3.69%	1.93%	3%	1.87%
2025/01/15	0.54%	2.94%	2.53%	2.66%	1.24%	2.9%	4.43%	2.87%	3.1%	2.24%
2025/01/16	0.48%	3.66%	2.39%	3.18%	2.38%	2.49%	4.67%	2.59%	3.47%	3.9%
2025/01/21	6.99%	10.65%	1.76%	3.71%	5.47%	0.11%	0.37%	0.23%	0.12%	0.89%
2025/01/22	8.61%	11.31%	1.96%	4.22%	4.86%	0.08%	0.42%	0.36%	0.37%	1.05%
2025/01/23	2.01%	5.33%	2.06%	4.11%	2.93%	1.38%	2.8%	0.8%	2.06%	2.73%
2025/01/24	3.61%	5.8%	3.02%	3.65%	2.94%	0.6%	2.06%	1.26%	1.59%	2.21%
2025/01/25	3.45%	6.94%	2.49%	3.15%	4.52%	0.29%	0.6%	0.18%	0.51%	1.44%
2025/01/26	7.36%	7.36%	3.05%	3.47%	6.63%	0.85%	0.98%	0.78%	0.92%	1.5%
2025/01/27	4.62%	6.51%	3.49%	3.05%	5.96%	0.62%	0.69%	0.49%	0.53%	1.03%
2025/01/28	4.26%	8.13%	2.95%	3.87%	3.47%	1.21%	1.68%	1.1%	1.18%	1.88%
2025/01/29	5.3%	4.71%	1.79%	3.93%	1.65%	2.11%	2.33%	1.66%	1.82%	1.79%
2025/01/30	5.81%	5.41%	2.42%	3.81%	1.61%	1.68%	2.07%	1.55%	1.56%	1.29%
2025/01/31	4.87%	3.29%	3.15%	2.77%	1.84%	1.56%	1.41%	1.09%	1.02%	0.8%

In January 2025, breyanzi.com led with a peak impression share of 11.31% on January 22. letschatcart.com followed closely, peaking at 8.61% on the same day. The month concluded with breyanzi.com maintaining dominance.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & biotech Oncology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

1
HER2+ eBC Treatment Info - Early Breast Cancer Treatments https://www.her2empowered.com
Patients - Familiarize Yourself With The HER2+ Early Breast Cancer Treatment Experience.
2
HR+, HER2- Breast Cancer Info - mBC Overall Survival Results Prescription treatment website
HCPs, Learn About HR+, HER2- Metastatic Breast Cancer And Discover A 1L Treatment Option.
3
What is CAR T-Cell Therapy? - Learn About CAR T-Cell Therapy Prescription treatment website
CAR T-Cell Therapy Helps Your Immune System Fight Against Certain Relapsed Blood Cancers.
4
Visit the HCP Website - Car-T for Multiple Myeloma https://www.mmissionpossible.co
Learn how ongoing research on novel binding domains can impact the future of BCMA Therapy.
5
What is Multiple Myeloma https://www.thermofisher.com › multiple › myeloma
What is myeloma — Multiple myeloma is the second most common blood cancer in the United States. Learn more.

In the competitive landscape of oncology PPC ads, HER2+ eBC Treatment Info stands out by empowering patients with early breast cancer treatment knowledge. Meanwhile, Kisqali-hcp.com targets healthcare professionals with insights on HR+, HER2- metastatic breast cancer. CAR T-Cell Therapy ads educate on innovative immune system treatments for blood cancers, while Mmissionpossible.co and Thermofisher.com focus on cutting-edge research and awareness of multiple myeloma, respectively. These ads collectively highlight a commitment to education and innovation in cancer treatment.

Frequently Asked Questions

Data within the PPC Market Share Report 2025 is aggregated every month, highlighting the most significant changes from the previous period.
We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
The PPC Marketing Share Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Yes. The PPC Market Share Report 2024 aggregates data from across both device types and Google Shopping.
The PPC Market Share Report 2024 is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI."Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Pharma & Biotech Oncology - PPC Market Share Analysis February 2025

Share of Clicks for top 10 US Pharma & biotech Oncology brands

Share of Spend for the top 10 US Pharma & biotech Oncology brands

Competitor Count for US Pharma & biotech Oncology

Market Loss & Market Gains for US Pharma & biotech Oncology

US Pharma & biotech Oncology Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Pharma & biotech Oncology

Frequently Asked Questions

Customer Success Stories

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization​ with Adthena

Sage case study: 75% decrease in CPCs with Adthena

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Get the full picture

See this data specific to your brand performance

the7stars Case Study: Achieving Google Ads PPC Campaign Optimization with Adthena